Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
ProShares Ultra Health Care(RXL)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for RXL
10/28/2026: RXL (2-star) is currently NOT-A-BUY. Pass it for now.
ProShares Ultra Health Care (RXL) is a leveraged ETF that aims to provide twice the daily return of the Dow Jones U.S. Health Care Index through the use of financial derivatives. It is an ideal tool for active traders looking to gain amplified exposure to the healthcare sector over a very short time horizon. Its main strength lies in its ability to facilitate tactical directional bets without the need for margin accounts, provided by a reputable issuer. However, investors must be wary of the structural risk of leverage decay, where the fund's value erodes over longer holding periods due to daily compounding. It is best suited for experienced, active investors who understand the risks of leveraged products and closely manage their positions.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | This fund is designed for short-term tactical trades rather than long-term growth investing. |
| Momentum investor | Strong fit while signal remains positive | It is highly effective for capturing short-term upward momentum in the healthcare sector. |
| Value investor | Weak fit | The daily rebalancing strategy is antithetical to the principles of long-term value investing. |
| Dividend/Income investor | Weak fit | This fund is a capital appreciation vehicle and not intended for income generation. |
| Low-risk investor | Weak fit | The 2x daily leverage creates a risk profile that is inherently unsuitable for risk-averse investors. |
Investor Profile
Ideal Investor Profile
Sophisticated retail traders and institutional investors seeking short-term tactical exposure to the healthcare sector.
Suitability
Best suited for active, short-term traders who monitor positions daily; highly unsuitable for long-term, passive investors.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Leverage amplifies daily price swings, leading to significant potential losses. |
| Market risk | High | The fund is directly exposed to the systemic risks of the U.S. healthcare sector. |
| Concentration | High | Performance depends entirely on the movement of a single economic sector. |
| Tracking/expense | Medium / high | Daily rebalancing and financing costs create significant tracking drift over time. |
| Liquidity | Medium | Volume can decline during sector-specific downturns, potentially impacting execution. |
| Business/sector quality | Medium | Regulatory changes in healthcare can have outsized impacts on the underlying index. |
Risk Analysis
Volatility
RXL exhibits significantly higher volatility than the underlying index due to the 2x daily leverage target.
Market Risk
The fund is vulnerable to any negative news cycle impacting healthcare, biotech, or pharmaceutical policy.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Dow Jones U.S. Health Care Index — seeks 2x daily return | 98 | This exposure provides amplified access to major U.S. healthcare companies including pharmaceuticals, biotech, and medical devices. |
| Cash/collateral | Cash and Cash Equivalents | 2 | Cash is held to maintain collateral requirements for the fund's derivative positions. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit 53.53% | Avg. Invested days 64 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/28/2026 |
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.